Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Colorcon
Moodys
Boehringer Ingelheim
McKinsey

Last Updated: September 26, 2022

ISONIAZID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Isoniazid patents expire, and what generic alternatives are available?

Isoniazid is a drug marketed by Sandoz Inc, Chartwell Rx, Cmp Pharma Inc, Barr, Duramed Pharms Barr, Epic Pharma Llc, Halsey, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Lilly, Mikart, Mk Labs, Nexgen Pharma Inc, Panray, Perrigo, Pharmavite, Phoenix Labs Ny, Purepac Pharm, Sun Pharm Industries, Thepharmanetwork Llc, Watson Labs, and Whiteworth Town Plsn. and is included in thirty-four NDAs.

The generic ingredient in ISONIAZID is isoniazid. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isoniazid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Isoniazid

A generic version of ISONIAZID was approved as isoniazid by MIKART on June 26th, 1997.

  Sign up for a Free Trial

Drug patent expirations by year for ISONIAZID
Drug Prices for ISONIAZID

See drug prices for ISONIAZID

Recent Clinical Trials for ISONIAZID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Aurum Institute NPCPhase 1/Phase 2
The Aurum Institute NPCPhase 4
Weill Medical College of Cornell UniversityPhase 1/Phase 2

See all ISONIAZID clinical trials

Pharmacology for ISONIAZID
Medical Subject Heading (MeSH) Categories for ISONIAZID

US Patents and Regulatory Information for ISONIAZID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs ISONIAZID isoniazid TABLET;ORAL 085784-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sun Pharm Industries ISONIAZID isoniazid TABLET;ORAL 083633-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Phoenix Labs Ny ISONIAZID isoniazid TABLET;ORAL 080368-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Thepharmanetwork Llc ISONIAZID isoniazid TABLET;ORAL 202610-001 Oct 29, 2014 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Purepac Pharm ISONIAZID isoniazid TABLET;ORAL 080132-003 Jul 14, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Express Scripts
Baxter
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.